Cytek Biosciences/CTKB

$8.85

0.91%
-
1D1W1MYTD1YMAX

About Cytek Biosciences

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells (Full Spectrum Profiling (FSP)). The Company’s FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize a method of light detection and distribution. The Company's FSP platform includes its instruments, the Aurora and Northern Lights systems; its cell sorter, the Aurora cell sorter (CS), and reagents, software and services to provide an integrated suite of solutions for its customers.

Ticker

CTKB

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Wenbin Jiang

Employees

688

Headquarters

Fremont, United States

CTKB Metrics

BasicAdvanced
$1.18B
Market cap
-
P/E ratio
-$0.11
EPS
-
Beta
-
Dividend rate

What the Analysts think about CTKB

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
12.99% upside
High $12.00
Low $7.00
$8.85
Current price
$10.00
Average price target

CTKB Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-13.33% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$48M
-3.23%
Net income
$-6.4M
48.84%
Profit margin
-13.33%
53.93%

CTKB Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 266.67%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.06
-$0.05
-$0.03
-$0.05
-
Expected
$0.05
$0.03
$0.03
$0.03
$0.00
Surprise
28.57%
-266.67%
-200%
-266.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Cytek Biosciences stock

Buy or sell Cytek Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing